Skip to content

Clinical trials

Phase 2 Pleural Effusion, Malignant trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion, Malignant Phase: Phase 2 Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20141
20151
20162
20181
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guizhou Medical University1
Haihong Yang, MD, Pricipal investigator1
Huazhong University of Science and Technology1
Jiangsu Simcere Pharmaceutical Co., Ltd.1
Peking University Cancer Hospital & Institute1
Shanghai Jeyou Pharmaceutical Co., Ltd.1
Shenzhen SiBiono GeneTech Co.,Ltd1
Tang-Du Hospital1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion, Malignant9
Carcinoma, Non-Small-Cell Lung2
Ascites1
Pericardial Effusion1
Pleural Effusion1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.